These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34900527)

  • 1. Gains from no real PAINS: Where 'Fair Trial Strategy' stands in the development of multi-target ligands.
    Sun J; Zhong H; Wang K; Li N; Chen L
    Acta Pharm Sin B; 2021 Nov; 11(11):3417-3432. PubMed ID: 34900527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Activity Profiles of PAINS and Their Structural Context in Target-Ligand Complexes.
    Siramshetty VB; Preissner R; Gohlke BO
    J Chem Inf Model; 2018 Sep; 58(9):1847-1857. PubMed ID: 30105913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Small-Molecule Reactivity Identifies Promiscuous Bioactive Compounds.
    Matlock MK; Hughes TB; Dahlin JL; Swamidass SJ
    J Chem Inf Model; 2018 Aug; 58(8):1483-1500. PubMed ID: 29990427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.
    Kumar A; Tiwari A; Sharma A
    Curr Neuropharmacol; 2018; 16(6):726-739. PubMed ID: 29542413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of multitarget-directed ligands against Alzheimer's disease through systematic prediction of chemical-protein interactions.
    Fang J; Li Y; Liu R; Pang X; Li C; Yang R; He Y; Lian W; Liu AL; Du GH
    J Chem Inf Model; 2015 Jan; 55(1):149-64. PubMed ID: 25531792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CADD Modeling of Multi-Target Drugs Against Alzheimer's Disease.
    Ambure P; Roy K
    Curr Drug Targets; 2017; 18(5):522-533. PubMed ID: 26343117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly Promiscuous Small Molecules from Biological Screening Assays Include Many Pan-Assay Interference Compounds but Also Candidates for Polypharmacology.
    Gilberg E; Jasial S; Stumpfe D; Dimova D; Bajorath J
    J Med Chem; 2016 Nov; 59(22):10285-10290. PubMed ID: 27809519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuisance Compounds, PAINS Filters, and Dark Chemical Matter in the GSK HTS Collection.
    Chakravorty SJ; Chan J; Greenwood MN; Popa-Burke I; Remlinger KS; Pickett SD; Green DVS; Fillmore MC; Dean TW; Luengo JI; Macarrón R
    SLAS Discov; 2018 Jul; 23(6):532-545. PubMed ID: 29699447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens.
    Huth JR; Mendoza R; Olejniczak ET; Johnson RW; Cothron DA; Liu Y; Lerner CG; Chen J; Hajduk PJ
    J Am Chem Soc; 2005 Jan; 127(1):217-24. PubMed ID: 15631471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward an Understanding of Pan-Assay Interference Compounds and Promiscuity: A Structural Perspective on Binding Modes.
    Bolz SN; Adasme MF; Schroeder M
    J Chem Inf Model; 2021 May; 61(5):2248-2262. PubMed ID: 33899463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P; Bhat J; Puzyn T; Roy K
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.
    Dahlin JL; Nissink JW; Strasser JM; Francis S; Higgins L; Zhou H; Zhang Z; Walters MA
    J Med Chem; 2015 Mar; 58(5):2091-113. PubMed ID: 25634295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS.
    Capuzzi SJ; Muratov EN; Tropsha A
    J Chem Inf Model; 2017 Mar; 57(3):417-427. PubMed ID: 28165734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds.
    Jasial S; Hu Y; Bajorath J
    J Med Chem; 2017 May; 60(9):3879-3886. PubMed ID: 28421750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting GAINs (Give Attention to Limitations in Assays) over PAINs Alerts: no PAINS, more GAINs.
    Choo MZY; Chai CLL
    ChemMedChem; 2022 Apr; 17(7):e202100710. PubMed ID: 35146933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation.
    Remya C; Dileep KV; Koti Reddy E; Mantosh K; Lakshmi K; Sarah Jacob R; Sajith AM; Jayadevi Variyar E; Anwar S; Zhang KYJ; Sadasivan C; Omkumar RV
    Comput Struct Biotechnol J; 2021; 19():4517-4537. PubMed ID: 34471497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Pharmacological Evaluation of
    Kumar B; Dwivedi AR; Arora T; Raj K; Prashar V; Kumar V; Singh S; Prakash J; Kumar V
    ACS Chem Neurosci; 2022 Jul; 13(14):2122-2139. PubMed ID: 35797244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on The Ecstasy and Agony of Assay Interference Compounds.
    Kenny PW
    J Chem Inf Model; 2017 Nov; 57(11):2640-2645. PubMed ID: 29048168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray Structures of Target-Ligand Complexes Containing Compounds with Assay Interference Potential.
    Gilberg E; Gütschow M; Bajorath J
    J Med Chem; 2018 Feb; 61(3):1276-1284. PubMed ID: 29328660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.